Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis

Kidney International

Volumn 81, Issue 2, 2012, Pages 190-195

  Barbour, Sean J ^a,b,c   Greenwald, Allen ^d   Djurdjev, Ognjenka ^b   Levin, Adeera ^a,b   Hladunewich, Michelle A ^c,e   Nachman, Patrick H ^f   Hogan, Susan L ^f   Cattran, Daniel C ^c,e   Reich, Heather N ^c,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Provincial Renal Agency   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

glomerulonephritis; membranous nephropathy; nephrotic syndrome; thrombosis

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENDER; HAZARD RATIO; HIGH RISK PATIENT; HISTOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 84855189409     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.312     Document Type: Article

References (19)

1. Canadian Institute for Health Information. 2010 Annual Report- Treatment of End-Stage Organ Failure in Canada, 1999 to 2008. http://secure.cihi.ca/ cihiweb/products/corr-annual-report-2010-e.pdf.
2. Kayali F, Najjar R, Aswad F, et al. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 2008; 121: 226-230. (Pubitemid 351317912)
3. Glassock RJ. Prophylactic anticoagulation in nephrotic syndrome: a clinical onundrum. J Am Soc Nephrol 2007; 18: 2221-2225. (Pubitemid 47203835)
4. Bellomo R, Atkins RC. Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 1993; 63: 249-254. (Pubitemid 23082063)
5. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-439. (Pubitemid 15248032)
6. Llach F, Koffler A, Finck E, et al. On the incidence of renal vein thrombosis in the nephrotic syndrome. Arch Intern Med 1977; 137: 333-336. (Pubitemid 9020959)
7. Llach F, Papper S, Massry SG. The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med 1980; 69: 819-827. (Pubitemid 11199851)
8. Velasquez Forero F, Garcia Prugue N, Ruiz Morales N. Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol 1988; 8: 457-462. (Pubitemid 19022759)
9. Chugh KS, Malik N, Uberoi HS, et al. Renal vein thrombosis in nephrotic syndrome-a prospective study and review. Postgrad Med J 1981; 57: 566-570. (Pubitemid 11046732)
10. Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117: 224-230.
11. Wagoner RD, Stanson AW, Holley KE, et al. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 1983; 23: 368-374. (Pubitemid 13148106)
12. Kendall AG, Lohmann RC, Dossetor JB. Nephrotic syndrome. A hypercoagulable state. Arch Intern Med 1971; 127: 1021-1027.
13. Bazzi C, Petrini C, Rizza V, et al. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin. Am J Kidney Dis 1997; 30: 404-412. (Pubitemid 27391510)
14. Wakui H, Imai H, Komatsuda A, et al. Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN). Clin Exp Immunol 1999; 118: 445-450.
15. Lopez-Alemany R, Longstaff C, Hawley S, et al. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am J Hematol 2003; 72: 234-242. (Pubitemid 36383973)
16. Elinav E, Rubinger D, Hiller N, et al. Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation: a mere coincidence? Thromb Haemost 2006; 95: 740-743.
17. Beck Jr LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
18. Regional program for the study of glomerulonephritis. Central Committee of the Toronto Glomerulonephritis Registry. Can Med Assoc J 1981; 124: 158-161.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.